Ex Parte LEVEILLE - Page 12


               Appeal No. 2000-1862                                                                                                   
               Application 08/834,061                                                                                                 

               feature in the “far UV range,” is unavailing because it is not necessary that a reference “teach”                      
               the claimed invention, only that the appealed claims “‘read on’ something disclosed in the                             
               reference, i.e., all limitations of the claims are found in the reference, or ‘fully met’ by it.”                      
               Kalman v. Kimberly-Clark Corp., 713 F.2d 760, 772, 218 USPQ 781, 789 (Fed. Cir. 1983); cf.                             
               Celeritas Technologies Ltd. V. Rockwell International Corp., 150 F.3d 1354, 1361, 47 USPQ2d                            
               1516, 1522 (Fed. Cir. 1998) (“[T]he question whether a reference ‘teaches away’ from the                               
               invention is inapplicable to an anticipation analysis.”).                                                              
                       Appellant further states that “[t]here is no mention in the Orignac reference” of the                          
               limitation set forth in appealed claims 3, 5 and 7, and apparently in the case of claim 5, that the                    
               “dopants must have a concentration many times that found in the materials disclosed in” the                            
               reference, without supplying the basis for these contentions (brief, page 5).  In response, the                        
               examiner explains how each of these limitations are expressly or inherently shown in Orignac                           
               (answer, pages 5-7), including the dual interpretation of the phrase “concentration of the rare-                       
               earth dopant” in claim 5 which we find to be a reasonable, conditional interpretation of this claim                    
               as explained above.  In the absence of rebuttal by appellant (reply brief in entirety), we find the                    
               examiner’s position to be reasonable on this record.  In this respect, we find that among the rare                     
               earth-doped sol-gel silica glass monoliths specifically shown in Orignac is the species containing                     
               “3 at. %” neodymium illustrated in Orignac FIG. 3.  It reasonably appears from Orignac that                            
               “~0.36 at. %” of this rare earth element is “1 wt %” when doped on “pure silica sol-gel glasses”                       
               (page 896).  Thus, on this record, the single species of FIG. 3 appears to be doped with about 9                       
               weight percent of neodymium, which anticipates the limitation of claim 5 as it stands on appeal.                       
               See Titanium Metals Corp. v. Banner, 778 F.2d 775, 781-83, 227 USPQ 773, 778-79 (Fed. Cir.                             
               1985).                                                                                                                 
                       Accordingly, based on our consideration of the totality of the record before us, we have                       
               weighed the evidence of anticipation found in Orignac with appellant’s countervailing evidence                         
               of and argument for no anticipation in fact and find that the claimed invention encompassed by                         
               appealed claims 2 through 15 are anticipated as a matter of fact under 35 U.S.C. § 102(a).                             
                       Turning now to the ground of rejection based on Xu, we find that, as a matter of fact, the                     
               examiner has established a prima facie case of anticipation of claims 37, 3 and 7, as we                               


                                                                - 12 -                                                                



Page:  Previous  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  Next 

Last modified: November 3, 2007